| 000 | 00693cam a2200145 4500500 | ||
|---|---|---|---|
| 005 | 20250121083948.0 | ||
| 041 | _afre | ||
| 042 | _adc | ||
| 100 | 1 | 0 |
_aBorchiellini, Delphine _eauthor |
| 245 | 0 | 0 | _aFirst-line management of advanced or metastatic clear cell renal cancer: How long should immunotherapy and/or anti-angiogenic therapy last? What are the criteria for stopping or continuing treatment? |
| 260 | _c2024. | ||
| 500 | _a19 | ||
| 786 | 0 | _nInnovations & Thérapeutiques en Oncologie | Volume 10 | Special Issue 1 | 2024-06-25 | p. 9-16 | 2431-3203 | |
| 856 | 4 | 1 | _uhttps://shs.cairn.info/journal-innovations-therapeutiques-en-oncologie-2024-HS1-page-9?lang=en&redirect-ssocas=7080 |
| 999 |
_c504515 _d504515 |
||